Indication
Genetic Predisposition
17 clinical trials
19 products
Clinical trial
Study of Family COsegregation of Nucleotide VARiants in the Panel of Genes to Validate Their Use in Genetic CounselingStatus: Recruiting, Estimated PCD: 2033-01-02
Product
Salivary KitClinical trial
PTX3 Genetically Stratified Randomized Double-blinded Allocation Event-driven Clinical Trial for Antifungal Prophylaxis in Patients With Acute Myeloid LeukemiaStatus: Recruiting, Estimated PCD: 2025-11-30
Product
PosaconazoleProduct
FluconazoleClinical trial
EXOME Analysis Position in the Strategy of Genetic Predisposition Factors Identification in Early-onset CancerStatus: Recruiting, Estimated PCD: 2026-10-07
Product
Blood SampleClinical trial
APOL1 Genetic Testing in African Americans: Exploring Attitudes About Genetic Risk to Improve Comprehensive Kidney Risk Assessment for Patients and FamiliesStatus: Recruiting, Estimated PCD: 2025-06-30
Product
APOL-1 renal risk variantClinical trial
Initiative for Clinical Long-read Sequencing - Towards Implementation of Long-read Genome Sequencing in Routine DiagnosticsStatus: Not yet recruiting, Estimated PCD: 2025-12-01
Product
Next-Generation SequencingClinical trial
Exploring the Genetics of Neuropathic PainStatus: Recruiting, Estimated PCD: 2027-01-01
Product
Nerve conduction StudiesClinical trial
Diagnostic Value of Exome and Genome Sequencing as Well as Conventional Methods in Rare Diseases and Familial Tumor SyndromesStatus: Recruiting, Estimated PCD: 2024-02-01
Product
Retrospective data analysisClinical trial
Pharmacogenetics of Hypertension: a Single-centre Randomized Study in Patients With Essential Hypertension Treated With Spironolactone or TorasemideStatus: Completed, Estimated PCD: 2023-07-07
Product
TorasemideProduct
SpironolactoneClinical trial
Genetic Based Analysis of Identifying Predictors of Blood Pressure Response in Hypertensive Patients After Renal DenervationStatus: Active (not recruiting), Estimated PCD: 2020-07-23
Clinical trial
Precision Medicine in the Prostate Cancer Care Pathway: an Evaluation of Integrating Germline Genetic Testing Into the Management of Men at Risk of / Living With Prostate CancerStatus: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGHStatus: Recruiting, Estimated PCD: 2027-05-31
Product
Oral SemaglutideClinical trial
Optimal Management of HIV Infected Adults at Risk for Kidney Complications in NigeriaStatus: , Estimated PCD: 2025-02-01
Product
LisinoprilClinical trial
Genetic Investigation of Cancer PredispositionStatus: Not yet recruiting, Estimated PCD: 2030-06-01
Product
DNA or RNA SequencingClinical trial
Comparative Genetic and Immune Response Analysis of Different COVID-19 Vaccine Candidates Using Multi-OMICS ApproachStatus: Recruiting, Estimated PCD: 2024-07-01
Product
Multi-OMICSClinical trial
Mitochondrial Diseases - Long-read Genome and Transcriptome Sequencing in Cases Unresolved After Short-read GenomicsStatus: Recruiting, Estimated PCD: 2024-02-01
Product
Next Generation SequencingClinical trial
In Situ Clonal Heterogeneity in Prostatic Diagnostic Biopsies: Impact on Prostate Cancer Evolution and Clinical Outcome. A Retrospective, Proof of Concept StudyStatus: Terminated, Estimated PCD: 2023-01-15
Clinical trial
Oncotype DX in BRCA-mutated Breast Cancer Patients: Our Experience. A Retrospective Observational Monocentric StudyStatus: Completed, Estimated PCD: 2021-12-31
Product
Oncotype DX